SIRPA and neoplasm: The authors also discovered that metastatic tumor cells tend to express the ligand CD47, an important “don’t-eat-me” signal (150), which may influence the anti-tumor immunity of MRC1+ CCL18+ macrophages via its corresponding receptor SIRPA (151).